Evaluation of the antimicrobial activity of β-lactam antibiotics by Etest against clinical isolates

Japanese Journal of Chemotherapy

Volumn 50, Issue 8, 2002, Pages 500-506

  Ishii, Yoshikazu ^a   Alba, Jimena ^a   Kimura, Soichiro ^a   Yamaguchi, Keizo ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

lactams; Cefepime; Drug resistance; Etest; Susceptibility

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFPIROME; CEFTAZIDIME; IMIPENEM; INDOLE; OXACILLIN; PIPERACILLIN; SULPERAZON;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CITROBACTER; CLINICAL PROTOCOL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG SCREENING; ENTEROBACTER; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEUS; PSEUDOMONAS AERUGINOSA; SERRATIA; STAPHYLOCOCCUS AUREUS;

EID: 0036696864     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Yoshihara E, Gotoh N, Nishino T, et al.: Protein D 2 porin of the Pseudomonas aeruginosa outer membrane bears the protease activity. FEBS Lett 394: 179-182, 1996
2. Masuda N, Sakagawa E, Ohya S, et al.: Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 44:3322-3327, 2000
3. Ubukata K, Shibasaki Y, Yamamoto K, et al.: Association of amino acid substitution in penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 45: 1693-1699, 2001
4. Japanese source. 48: 524-530, 2000
5. Japanese source. 50: 259-265, 2002
6. National Committee for Clinical Laboratory Standard. 2000. Methods for dilution antimicrobial susceptibility test for bacteria. M7-A 5. Vol. 20. No. 2
7. Yagi T, Kurokawa H, Shibata N, et al.: A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol Lett 184: 53-56, 2000
8. IMP. antimicrob. agents chemother. 42: 2006-2011, 1998
9. Hiraoka M, Inoue M, Mitsuhashi S: Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins. Rev Infect Dis. 10: 746-751, 1988
10. Hiraoka M, Masuyoshi S, Mitsuhashi S, et al.: Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime. J Antibiot (Tokyo). 41: 86-93, 1988